Announcements Trials
Browse Landscape

Phase

Phase 1 48Phase 2 17Phase 1/2 6Phase EARLY_PHASE1 3Phase NA 2Phase 3 1

Status

Completed 4Unknown 2

Sponsor Class

INDUSTRY 30OTHER 6OTHER_GOV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other solid neoplasm 6

Conditions

Breast Neoplasms 320Leukemia, Myeloid, Acute 266Multiple Myeloma 227Carcinoma, Non-Small-Cell Lung 224Prostatic Neoplasms 202Neoplasms 196Lymphoma 191Colorectal Neoplasms 184Melanoma 179Leukemia 170Recurrence 164Pancreatic Neoplasms 163Precursor Cell Lymphoblastic Leukemia-Lymphoma 160Lung Neoplasms 150Glioblastoma 134Neoplasm Metastasis 132Lymphoma, Non-Hodgkin 128Ovarian Neoplasms 123Leukemia, Lymphocytic, Chronic, B-Cell 120Myelodysplastic Syndromes 117Lymphoma, Large B-Cell, Diffuse 110Lymphoma, Mantle-Cell 108Carcinoma, Hepatocellular 103Lymphoma, Follicular 99Stomach Neoplasms 96Carcinoma, Renal Cell 89Hodgkin Disease 88Brain Neoplasms 88Sarcoma 84Burkitt Lymphoma 75

Interventions

pazopanib 1Topotecan 1HLA-A*24:02 antigen 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Solid Tumors × Clear all
NCT04627740 2026-01-20

Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors

Xinqiao Hospital of Chongqing

Phase 1/2 Completed
5 enrolled
Other solid neoplasm

Solid Tumors

NCT02303028 2022-06-28

TOPAZ

The Hospital for Sick Children

Phase 1/2 Completed
30 enrolled
Other solid neoplasm

Solid Tumors

NCT04937842 2021-06-24

Microtransplantation for Advanced and Relapsed Solid Tumors

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Phase 1/2 Unknown
60 enrolled
Other solid neoplasm

Solid Tumors

NCT01949688 2019-03-19

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid Tumors

Shiga University

Phase 1/2 Completed
26 enrolled
Other solid neoplasm

Solid Tumors

NCT02858232 2016-08-11

MASCT-I Treatment for Advanced Solid Tumor

The First People's Hospital of Lianyungang

Phase 1/2 Unknown
46 enrolled
Other solid neoplasm

Solid Tumors

NCT00703378 2012-03-28

Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle

National University Hospital, Singapore

Phase 1/2 Completed
33 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡